1058096
Last Update Posted: 2017-04-17
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
323 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Safety and Efficacy of Cariprazine for Mania
The objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine monotherapy versus placebo for the treatment of acute manic or mixed episodes associated with bipolar I disorder.
Eligibility
Relevant conditions:
Bipolar Disorder
Mania
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov